Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.

导出 OA

翻译打印收藏纠错

作者： Lenka,Besse ^[1] ; Lenka,Sedlarikova ^[1] ; Fedor,Kryukov ^[2] ; Jana,Nekvindova ^[3] ; Lenka,Radova ^[4] ; Ondrej,Slaby ^[4] ; Petr,Kuglik ^[5] ; Martina,Almasi ^[1] ; Miroslav,Penka ^[6] ; Marta,Krejci ^[7] ; Zdenek,Adam ^[7] ; Ludek,Pour ^[7] ; Sabina,Sevcikova ^[1] ; Roman,Hajek ^[8]

作者单位： Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. ^[1] Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Hematooncology, Faculty of Medicine University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic. ^[2] Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine and Faculty Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. ^[3] Central European Institute of Technology, Masaryk University, Brno, Czech Republic. ^[4] Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. ^[5] Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. ^[6] Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic. ^[7] Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic; Department of Hematooncology, Faculty of Medicine University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic. ^[8]